InMed Pharmaceuticals (INM) Non Operating Income (2023 - 2024)
InMed Pharmaceuticals (INM) posted Non Operating Income of $103421.0 for Q2 2024, down 14.85% on a QoQ basis from $121458.0 in Q1 2024, and down 30.29% year-over-year from $148357.0 in Q3 2023.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Non Operating Income (2023 - 2024) Analysis & Trends
InMed Pharmaceuticals has reported Non Operating Income for 2 years, with the latest figure at $103421.0 in Q2 2024.
- On a quarterly basis, Non Operating Income fell 30.29% year-over-year to $103421.0 in Q2 2024; TTM through Jun 2024 was $528803.0, a N/A change from a year earlier, with the FY2024 full-year figure at $527901.0, up 7.2% from the prior year.
- Non Operating Income was $103421.0 for Q2 2024 at InMed Pharmaceuticals, down from $121458.0 in the prior quarter.
- The five-year high for Non Operating Income was $155567.0 in Q1 2023, with the low at $103421.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.10 Bn | 142.60 Bn | 1.63 Bn | - |
| 2 | Ati | 28.39 Bn | 27.61 Bn | 309.80 Mn | - |
| 3 | Qnity Electronics | 26.40 Bn | 25.44 Bn | 666.00 Mn | -27.00 Mn |
| 4 | International Flavors & Fragrances | 21.54 Bn | 20.97 Bn | 853.00 Mn | - |
| 5 | DuPont de Nemours | 17.57 Bn | 15.83 Bn | 639.00 Mn | 42.00 Mn |
| 6 | Avery Dennison | 13.04 Bn | 12.81 Bn | 729.40 Mn | - |
| 7 | Solstice Advanced Materials | 10.13 Bn | 9.38 Bn | 370.00 Mn | - |
| 8 | Element Solutions | 8.78 Bn | 8.59 Bn | 334.00 Mn | -6.60 Mn |
| 9 | Eastman Chemical | 7.84 Bn | 7.15 Bn | 560.00 Mn | -14.00 Mn |
| 10 | InMed Pharmaceuticals | 5.35 Mn | 105,654.12 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 103,421.00 |
| Mar 31, 2024 | 121,458.00 |
| Jun 30, 2023 | 148,357.00 |
| Mar 31, 2023 | 155,567.00 |